What is PAYO's health score?

Payoneer Global Inc. (PAYO) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PAYO's estimated fair value?

Based on our 5-year discounted cash flow model, Payoneer Global Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is PAYO undervalued or overvalued?

Our model currently rates PAYO as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Get live scores & alerts on your phone

📱 Get the App

1 free score card remaining

Payoneer Global Inc. (PAYO)

Technology Inconclusive inconclusive mixed

$7.11

Updated: 2026-07-14

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

55 Mixed

Relative Value

45 Mixed

Capital Allocation

50 Mixed

Risk Management

50 Mixed

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Altman Z-Score in distress zone — elevated bankruptcy risk

Unlock Full Report →

Industry Related Stocks

Accenture plc (ACN) ACV Auctions Inc. (ACVA) Advantage Solutions Inc. (ADV) Akso Health Group (AHG) AKAMAI TECHNOLOGIES INC (AKAM) Alight, Inc. / Delaware (ALIT)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.